Global Recombinant Vaccines Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Recombinant Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Recombinant Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Recombinant Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Recombinant Vaccines Segment by Type

2.2.1 Subunit Recombinant Vaccines

2.2.2 Attenuated Recombinant Vaccines

2.2.3 Vector Recombinant Vaccines

2.3 Recombinant Vaccines Sales by Type

2.3.1 Global Recombinant Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Recombinant Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Recombinant Vaccines Sale Price by Type (2017-2022)

2.4 Recombinant Vaccines Segment by Application

2.4.1 Recombinant Human Vaccines

2.4.2 Animal Recombinant Vaccines

2.5 Recombinant Vaccines Sales by Application

2.5.1 Global Recombinant Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Recombinant Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Recombinant Vaccines Sale Price by Application (2017-2022)

3 Global Recombinant Vaccines by Company

3.1 Global Recombinant Vaccines Breakdown Data by Company

3.1.1 Global Recombinant Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Recombinant Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Recombinant Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Recombinant Vaccines Revenue by Company (2020-2022)

3.2.2 Global Recombinant Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Recombinant Vaccines Sale Price by Company

3.4 Key Manufacturers Recombinant Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Recombinant Vaccines Product Location Distribution

3.4.2 Players Recombinant Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Recombinant Vaccines by Geographic Region

4.1 World Historic Recombinant Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Recombinant Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Recombinant Vaccines Annual Revenue by Geographic Region

4.2 World Historic Recombinant Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Recombinant Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Recombinant Vaccines Annual Revenue by Country/Region

4.3 Americas Recombinant Vaccines Sales Growth

4.4 APAC Recombinant Vaccines Sales Growth

4.5 Europe Recombinant Vaccines Sales Growth

4.6 Middle East & Africa Recombinant Vaccines Sales Growth

5 Americas

5.1 Americas Recombinant Vaccines Sales by Country

5.1.1 Americas Recombinant Vaccines Sales by Country (2017-2022)

5.1.2 Americas Recombinant Vaccines Revenue by Country (2017-2022)

5.2 Americas Recombinant Vaccines Sales by Type

5.3 Americas Recombinant Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Recombinant Vaccines Sales by Region

6.1.1 APAC Recombinant Vaccines Sales by Region (2017-2022)

6.1.2 APAC Recombinant Vaccines Revenue by Region (2017-2022)

6.2 APAC Recombinant Vaccines Sales by Type

6.3 APAC Recombinant Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Recombinant Vaccines by Country

7.1.1 Europe Recombinant Vaccines Sales by Country (2017-2022)

7.1.2 Europe Recombinant Vaccines Revenue by Country (2017-2022)

7.2 Europe Recombinant Vaccines Sales by Type

7.3 Europe Recombinant Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Recombinant Vaccines by Country

8.1.1 Middle East & Africa Recombinant Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Recombinant Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Recombinant Vaccines Sales by Type

8.3 Middle East & Africa Recombinant Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Recombinant Vaccines

10.3 Manufacturing Process Analysis of Recombinant Vaccines

10.4 Industry Chain Structure of Recombinant Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Recombinant Vaccines Distributors

11.3 Recombinant Vaccines Customer

12 World Forecast Review for Recombinant Vaccines by Geographic Region

12.1 Global Recombinant Vaccines Market Size Forecast by Region

12.1.1 Global Recombinant Vaccines Forecast by Region (2023-2028)

12.1.2 Global Recombinant Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Recombinant Vaccines Forecast by Type

12.7 Global Recombinant Vaccines Forecast by Application

13 Key Players Analysis

13.1 Merck & Co., Inc

13.1.1 Merck & Co., Inc Company Information

13.1.2 Merck & Co., Inc Recombinant Vaccines Product Offered

13.1.3 Merck & Co., Inc Recombinant Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Merck & Co., Inc Main Business Overview

13.1.5 Merck & Co., Inc Latest Developments

13.2 Green Cross Corporation

13.2.1 Green Cross Corporation Company Information

13.2.2 Green Cross Corporation Recombinant Vaccines Product Offered

13.2.3 Green Cross Corporation Recombinant Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Green Cross Corporation Main Business Overview

13.2.5 Green Cross Corporation Latest Developments

13.3 Pfizer Inc.

13.3.1 Pfizer Inc. Company Information

13.3.2 Pfizer Inc. Recombinant Vaccines Product Offered

13.3.3 Pfizer Inc. Recombinant Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pfizer Inc. Main Business Overview

13.3.5 Pfizer Inc. Latest Developments

13.4 Bayer AG

13.4.1 Bayer AG Company Information

13.4.2 Bayer AG Recombinant Vaccines Product Offered

13.4.3 Bayer AG Recombinant Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Bayer AG Main Business Overview

13.4.5 Bayer AG Latest Developments

13.5 Sanofi S A.

13.5.1 Sanofi S A. Company Information

13.5.2 Sanofi S A. Recombinant Vaccines Product Offered

13.5.3 Sanofi S A. Recombinant Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Sanofi S A. Main Business Overview

13.5.5 Sanofi S A. Latest Developments

13.6 Protein Science Corporation

13.6.1 Protein Science Corporation Company Information

13.6.2 Protein Science Corporation Recombinant Vaccines Product Offered

13.6.3 Protein Science Corporation Recombinant Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Protein Science Corporation Main Business Overview

13.6.5 Protein Science Corporation Latest Developments

13.7 GlaxoSmithKline Plc.

13.7.1 GlaxoSmithKline Plc. Company Information

13.7.2 GlaxoSmithKline Plc. Recombinant Vaccines Product Offered

13.7.3 GlaxoSmithKline Plc. Recombinant Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 GlaxoSmithKline Plc. Main Business Overview

13.7.5 GlaxoSmithKline Plc. Latest Developments

13.8 Novartis AG

13.8.1 Novartis AG Company Information

13.8.2 Novartis AG Recombinant Vaccines Product Offered

13.8.3 Novartis AG Recombinant Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Novartis AG Main Business Overview

13.8.5 Novartis AG Latest Developments

13.9 Bharat Biotech

13.9.1 Bharat Biotech Company Information

13.9.2 Bharat Biotech Recombinant Vaccines Product Offered

13.9.3 Bharat Biotech Recombinant Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Bharat Biotech Main Business Overview

13.9.5 Bharat Biotech Latest Developments

14 Research Findings and Conclusion

Table 1. Recombinant Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Recombinant Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Subunit Recombinant Vaccines

Table 4. Major Players of Attenuated Recombinant Vaccines

Table 5. Major Players of Vector Recombinant Vaccines

Table 6. Global Recombinant Vaccines Sales by Type (2017-2022) & (K Units)

Table 7. Global Recombinant Vaccines Sales Market Share by Type (2017-2022)

Table 8. Global Recombinant Vaccines Revenue by Type (2017-2022) & ($ million)

Table 9. Global Recombinant Vaccines Revenue Market Share by Type (2017-2022)

Table 10. Global Recombinant Vaccines Sale Price by Type (2017-2022) & (USD/Unit)

Table 11. Global Recombinant Vaccines Sales by Application (2017-2022) & (K Units)

Table 12. Global Recombinant Vaccines Sales Market Share by Application (2017-2022)

Table 13. Global Recombinant Vaccines Revenue by Application (2017-2022)

Table 14. Global Recombinant Vaccines Revenue Market Share by Application (2017-2022)

Table 15. Global Recombinant Vaccines Sale Price by Application (2017-2022) & (USD/Unit)

Table 16. Global Recombinant Vaccines Sales by Company (2020-2022) & (K Units)

Table 17. Global Recombinant Vaccines Sales Market Share by Company (2020-2022)

Table 18. Global Recombinant Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Recombinant Vaccines Revenue Market Share by Company (2020-2022)

Table 20. Global Recombinant Vaccines Sale Price by Company (2020-2022) & (USD/Unit)

Table 21. Key Manufacturers Recombinant Vaccines Producing Area Distribution and Sales Area

Table 22. Players Recombinant Vaccines Products Offered

Table 23. Recombinant Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Recombinant Vaccines Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Recombinant Vaccines Sales Market Share Geographic Region (2017-2022)

Table 28. Global Recombinant Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Recombinant Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Recombinant Vaccines Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Recombinant Vaccines Sales Market Share by Country/Region (2017-2022)

Table 32. Global Recombinant Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Recombinant Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Recombinant Vaccines Sales by Country (2017-2022) & (K Units)

Table 35. Americas Recombinant Vaccines Sales Market Share by Country (2017-2022)

Table 36. Americas Recombinant Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Recombinant Vaccines Revenue Market Share by Country (2017-2022)

Table 38. Americas Recombinant Vaccines Sales by Type (2017-2022) & (K Units)

Table 39. Americas Recombinant Vaccines Sales Market Share by Type (2017-2022)

Table 40. Americas Recombinant Vaccines Sales by Application (2017-2022) & (K Units)

Table 41. Americas Recombinant Vaccines Sales Market Share by Application (2017-2022)

Table 42. APAC Recombinant Vaccines Sales by Region (2017-2022) & (K Units)

Table 43. APAC Recombinant Vaccines Sales Market Share by Region (2017-2022)

Table 44. APAC Recombinant Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Recombinant Vaccines Revenue Market Share by Region (2017-2022)

Table 46. APAC Recombinant Vaccines Sales by Type (2017-2022) & (K Units)

Table 47. APAC Recombinant Vaccines Sales Market Share by Type (2017-2022)

Table 48. APAC Recombinant Vaccines Sales by Application (2017-2022) & (K Units)

Table 49. APAC Recombinant Vaccines Sales Market Share by Application (2017-2022)

Table 50. Europe Recombinant Vaccines Sales by Country (2017-2022) & (K Units)

Table 51. Europe Recombinant Vaccines Sales Market Share by Country (2017-2022)

Table 52. Europe Recombinant Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Recombinant Vaccines Revenue Market Share by Country (2017-2022)

Table 54. Europe Recombinant Vaccines Sales by Type (2017-2022) & (K Units)

Table 55. Europe Recombinant Vaccines Sales Market Share by Type (2017-2022)

Table 56. Europe Recombinant Vaccines Sales by Application (2017-2022) & (K Units)

Table 57. Europe Recombinant Vaccines Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Recombinant Vaccines Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Recombinant Vaccines Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Recombinant Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Recombinant Vaccines Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Recombinant Vaccines Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Recombinant Vaccines Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Recombinant Vaccines Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Recombinant Vaccines Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Recombinant Vaccines

Table 67. Key Market Challenges & Risks of Recombinant Vaccines

Table 68. Key Industry Trends of Recombinant Vaccines

Table 69. Recombinant Vaccines Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Recombinant Vaccines Distributors List

Table 72. Recombinant Vaccines Customer List

Table 73. Global Recombinant Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Recombinant Vaccines Sales Market Forecast by Region

Table 75. Global Recombinant Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Recombinant Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Recombinant Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Recombinant Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Recombinant Vaccines Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Recombinant Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Recombinant Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Recombinant Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Recombinant Vaccines Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Recombinant Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Recombinant Vaccines Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Recombinant Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Recombinant Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Recombinant Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Recombinant Vaccines Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Recombinant Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Recombinant Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Recombinant Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 93. Merck & Co., Inc Basic Information, Recombinant Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 94. Merck & Co., Inc Recombinant Vaccines Product Offered

Table 95. Merck & Co., Inc Recombinant Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 96. Merck & Co., Inc Main Business

Table 97. Merck & Co., Inc Latest Developments

Table 98. Green Cross Corporation Basic Information, Recombinant Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 99. Green Cross Corporation Recombinant Vaccines Product Offered

Table 100. Green Cross Corporation Recombinant Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 101. Green Cross Corporation Main Business

Table 102. Green Cross Corporation Latest Developments

Table 103. Pfizer Inc. Basic Information, Recombinant Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 104. Pfizer Inc. Recombinant Vaccines Product Offered

Table 105. Pfizer Inc. Recombinant Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 106. Pfizer Inc. Main Business

Table 107. Pfizer Inc. Latest Developments

Table 108. Bayer AG Basic Information, Recombinant Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 109. Bayer AG Recombinant Vaccines Product Offered

Table 110. Bayer AG Recombinant Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 111. Bayer AG Main Business

Table 112. Bayer AG Latest Developments

Table 113. Sanofi S A. Basic Information, Recombinant Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 114. Sanofi S A. Recombinant Vaccines Product Offered

Table 115. Sanofi S A. Recombinant Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 116. Sanofi S A. Main Business

Table 117. Sanofi S A. Latest Developments

Table 118. Protein Science Corporation Basic Information, Recombinant Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 119. Protein Science Corporation Recombinant Vaccines Product Offered

Table 120. Protein Science Corporation Recombinant Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 121. Protein Science Corporation Main Business

Table 122. Protein Science Corporation Latest Developments

Table 123. GlaxoSmithKline Plc. Basic Information, Recombinant Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 124. GlaxoSmithKline Plc. Recombinant Vaccines Product Offered

Table 125. GlaxoSmithKline Plc. Recombinant Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 126. GlaxoSmithKline Plc. Main Business

Table 127. GlaxoSmithKline Plc. Latest Developments

Table 128. Novartis AG Basic Information, Recombinant Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 129. Novartis AG Recombinant Vaccines Product Offered

Table 130. Novartis AG Recombinant Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 131. Novartis AG Main Business

Table 132. Novartis AG Latest Developments

Table 133. Bharat Biotech Basic Information, Recombinant Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 134. Bharat Biotech Recombinant Vaccines Product Offered

Table 135. Bharat Biotech Recombinant Vaccines Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 136. Bharat Biotech Main Business

Table 137. Bharat Biotech Latest Developments

List of Figures

Figure 1. Picture of Recombinant Vaccines

Figure 2. Recombinant Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Recombinant Vaccines Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Recombinant Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Recombinant Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Subunit Recombinant Vaccines

Figure 10. Product Picture of Attenuated Recombinant Vaccines

Figure 11. Product Picture of Vector Recombinant Vaccines

Figure 12. Global Recombinant Vaccines Sales Market Share by Type in 2021

Figure 13. Global Recombinant Vaccines Revenue Market Share by Type (2017-2022)

Figure 14. Recombinant Vaccines Consumed in Recombinant Human Vaccines

Figure 15. Global Recombinant Vaccines Market: Recombinant Human Vaccines (2017-2022) & (K Units)

Figure 16. Recombinant Vaccines Consumed in Animal Recombinant Vaccines

Figure 17. Global Recombinant Vaccines Market: Animal Recombinant Vaccines (2017-2022) & (K Units)

Figure 18. Global Recombinant Vaccines Sales Market Share by Application (2017-2022)

Figure 19. Global Recombinant Vaccines Revenue Market Share by Application in 2021

Figure 20. Recombinant Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 21. Global Recombinant Vaccines Revenue Market Share by Company in 2021

Figure 22. Global Recombinant Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 23. Global Recombinant Vaccines Revenue Market Share by Geographic Region in 2021

Figure 24. Global Recombinant Vaccines Sales Market Share by Region (2017-2022)

Figure 25. Global Recombinant Vaccines Revenue Market Share by Country/Region in 2021

Figure 26. Americas Recombinant Vaccines Sales 2017-2022 (K Units)

Figure 27. Americas Recombinant Vaccines Revenue 2017-2022 ($ Millions)

Figure 28. APAC Recombinant Vaccines Sales 2017-2022 (K Units)

Figure 29. APAC Recombinant Vaccines Revenue 2017-2022 ($ Millions)

Figure 30. Europe Recombinant Vaccines Sales 2017-2022 (K Units)

Figure 31. Europe Recombinant Vaccines Revenue 2017-2022 ($ Millions)

Figure 32. Middle East & Africa Recombinant Vaccines Sales 2017-2022 (K Units)

Figure 33. Middle East & Africa Recombinant Vaccines Revenue 2017-2022 ($ Millions)

Figure 34. Americas Recombinant Vaccines Sales Market Share by Country in 2021

Figure 35. Americas Recombinant Vaccines Revenue Market Share by Country in 2021

Figure 36. United States Recombinant Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 37. Canada Recombinant Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 38. Mexico Recombinant Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 39. Brazil Recombinant Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 40. APAC Recombinant Vaccines Sales Market Share by Region in 2021

Figure 41. APAC Recombinant Vaccines Revenue Market Share by Regions in 2021

Figure 42. China Recombinant Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 43. Japan Recombinant Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 44. South Korea Recombinant Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. Southeast Asia Recombinant Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. India Recombinant Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. Australia Recombinant Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 48. Europe Recombinant Vaccines Sales Market Share by Country in 2021

Figure 49. Europe Recombinant Vaccines Revenue Market Share by Country in 2021

Figure 50. Germany Recombinant Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 51. France Recombinant Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 52. UK Recombinant Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. Italy Recombinant Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. Russia Recombinant Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 55. Middle East & Africa Recombinant Vaccines Sales Market Share by Country in 2021

Figure 56. Middle East & Africa Recombinant Vaccines Revenue Market Share by Country in 2021

Figure 57. Egypt Recombinant Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 58. South Africa Recombinant Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 59. Israel Recombinant Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. Turkey Recombinant Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. GCC Country Recombinant Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 62. Manufacturing Cost Structure Analysis of Recombinant Vaccines in 2021

Figure 63. Manufacturing Process Analysis of Recombinant Vaccines

Figure 64. Industry Chain Structure of Recombinant Vaccines

Figure 65. Channels of Distribution

Figure 66. Distributors Profiles